Adapting cardiovascular risk prediction models to different populations: the need for recalibration

Eur Heart J. 2024 Jan 7;45(2):129-131. doi: 10.1093/eurheartj/ehad748.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Heart Disease Risk Factors
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Risk Assessment
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors